Image-Guided Stereotactic Biopsy of High Grade Gliomas

Completed · Not applicable

Conditions studied: Brain Cancer, Glioma

In brief

The purpose of this study is to evaluate high and low areas of growth, or proliferation, within the tumor. An imaging technique using a very small amount of a radioactive tracer called 18Ffluoro-deoxy-L-thymidine (18F-FLT) can detect areas of rapid growth within the tumor. This imaging technique is called a FLT PET imaging. This present study involves obtaining one scan using FLT PET imaging. The goal of this study is to investigate associations between the imaging findings showing differences in growth rate within the tumor and the biology of the tumor that is measured in the sampled tumor tissue. This information may be used in future brain tumor patients to determine the best combination of treatment for individual patients. These studies may also improve our understanding of the types of changes taking place in brain tumor tissue that could improve individual patient outcome. FLT is produced for human use by the MSKCC cyclotron facility under an investigational new drug (IND) approval issued by the US Food and Drug Administration (FDA). This means that FLT is produced under strict rules and regulations, is considered safe, and has been approved for use in humans for certain disease conditions. 18F-FLT has been used in several research studies to date at this institution.

Key facts

Study ID

NCT00979810

Run by

Memorial Sloan Kettering Cancer Center

People needed

11

Starts

2009-09-16

Expected to finish

2020-02-24

Last updated by the study team

2020-12-17

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > or = to 18 years old.
• Radiographic appearance of a lesion presumed to be high-grade glioma.
• Planned surgical resection.

You may not qualify if…

• All patients who have been previously treated with radiation, chemotherapy, or other targeted drugs (patients only) for their brain tumor.
• Pregnant (confirmed by serum b-HCG in women of reproductive age) or breast feeding.
• Patients with other active malignancies or prior treatment for non-CNS malignancies.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.